'Lipitor launch postive for Ranbaxy'
Dilip Bhat, joint MD at Prabhudas Lilladher says stock of Ranbaxy looks good after the launch of generic version of Lipitor. The firm will generate significant amount of cash and its debt is expected to come down.
